TODAY'S HEADLINES
Monday, May 21, 2012
Your Money
Laura Joszt
After a disappointing end to 2011 regarding its lead drug, Exelixis is looking to bounce back with new data in its ASCO abstracts.
Roccy DeFrancesco, JD
When doctors are pitched asset protection planning by a local or national guru, what they are pitched is not even half of what needs to be done to have a complete asset protection plan.
Laura Joszt
The run up of stocks before the American Society of Clinical Oncology conference has begun if Array BioPharma’s stock jump is any indication.
Henry Stimpson
While you probably don’t have an antique that’s “a national treasure” lying around, you may have some unusually valuable possessions that call for special insurance coverage.
Your Practice
Daniel S. Levine
Osiris Therapeutics said it has received approval from Health Canada to market its stem cell therapy Prochymal for the treatment of acute graft-vs-host disease in children.
Laura Joszt
In honor of the upcoming ASCO conference, here are the top 10 best-selling cancer drugs based on how much in U.S. sales they brought in last year.
Laura Joszt
Health care facilities are looking more and more toward temporary doctors to fill the vacancies from full-time physician shortages. Since full-time physicians are often highly stressed, more could appreciate the flexibility that a locum tenens career offers.
John Teixeira, CPA, MST, and Kevin Bickerstaff, CPA
Buy-sell agreements are the cornerstone in the succession plan of any business; This especially holds true with physician-owned practices.
Eric Anderson, MD, and Nancy Anderson, RN
History abounds in Prague, from the famous church St. Vitus to the even more famous Old Town Clock to the lonely grave of the freedom fighter buried near Loretto Chapel.